The emergence of COVID-19 may have a significant impact on financial reporting and particularly on fair value estimation and impairment assessments. Therefore, it is considered imperative that professionals and management staff understand how COVID-19 may affect the valuation process, in the context of fair value and impairment testing. This training will provide insights on how key valuation parameters may change, as a result of the pandemic and how to capitalize on the lessons learned.

For more information, visit website

For more information, please contact: